Syquant Capital Sas Horizon Therapeutics Public LTD CO Transaction History

Syquant Capital Sas

  • $63.5 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 12, 2023
BUY
$98.98 - $115.74 $54 Million - $63.2 Million
545,824 Added 63.98%
1,398,990 $162 Million
Q2 2023

Jul 10, 2023
BUY
$96.34 - $112.38 $56 Million - $65.4 Million
581,549 Added 214.11%
853,166 $87.7 Million
Q1 2023

Apr 12, 2023
BUY
$107.32 - $113.5 $29.1 Million - $30.8 Million
271,617 New
271,617 $29.6 Million

Others Institutions Holding HZNP

# of Institutions
39
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Syquant Capital Sas Portfolio

Follow Syquant Capital Sas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syquant Capital Sas, based on Form 13F filings with the SEC.

News

Stay updated on Syquant Capital Sas with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email